| 11302940
|
Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease. |
Drug Metab Dispos |
2001 |
Zhang KE;Hee B;Lee CA;Liang B;Potts BC |
View
More |
| 15921461
|
Human rhinovirus 3C protease: generation of pharmacophore models for peptidic and nonpeptidic inhibitors and their application in virtual screening. |
J Chem Inf Model |
2005 |
Steindl T;Laggner C;Langer T |
View
More |
| 21936817
|
Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery. |
Biochem Soc Trans |
2011 |
Ramajayam R;Tan KP;Liang PH |
View
More |
| 23388726
|
3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses. |
J Virol |
2013 |
Tan J;George S;Kusov Y;Perbandt M;Anemuller S;Mesters JR;Norder H;Coutard B;Lacroix C;Leyssen P;Neyts J;Hilgenfeld R |
View
More |
| 23549610
|
The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles\' heel": current effective inhibitor targeting a 3C-like protease. |
Protein Cell |
2013 |
Ren Z;Yan L;Zhang N;Guo Y;Yang C;Lou Z;Rao Z |
View
More |
| 26055377
|
The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir. |
Antimicrob Agents Chemother |
2015 |
Lacroix C;George S;Leyssen P;Hilgenfeld R;Neyts J |
View
More |
| 27645381
|
Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease. |
Sci Rep |
2016 |
Tan YW;Ang MJ;Lau QY;Poulsen A;Ng FM;Then SW;Peng J;Hill J;Hong WJ;Chia CS;Chu JJ |
View
More |
| 30352199
|
Development of a homogeneous time-resolved fluorescence assay for detection of viral double-stranded RNA. |
Anal Biochem |
2019 |
Fujita M;Adachi K;Nagasawa M |
View
More |
| 30646829
|
Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study. |
J Biomol Struct Dyn |
2020 |
Jain S;Amin SA;Adhikari N;Jha T;Gayen S |
View
More |
| 33515606
|
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development. |
Antiviral Res |
2021 |
Liu C;Boland S;Scholle MD;Bardiot D;Marchand A;Chaltin P;Blatt LM;Beigelman L;Symons JA;Raboisson P;Gurard-Levin ZA;Vandyck K;Deval J |
View
More |
| 33641023
|
Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M(pro)) of SARS-CoV-2. |
J Mol Model |
2021 |
Ghosh A;Chakraborty M;Chandra A;Alam MP |
View
More |
| 34960671
|
RIPK1 Is Cleaved by 3C Protease of Rhinovirus A and B Strains and Minor and Major Groups. |
Viruses |
2021 |
Croft SN;Walker EJ;Ghildyal R |
View
More |
| 35278580
|
Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors. |
Antiviral Res |
2022 |
Scholle MD;O'Kane PT;Dib S;Gurard-Levin ZA |
View
More |
| 7794931
|
Peptide aldehyde inhibitors of hepatitis A virus 3C proteinase. |
Biochemistry |
1995 |
Malcolm BA;Lowe C;Shechosky S;McKay RT;Yang CC;Shah VJ;Simon RJ;Vederas JC;Santi DV |
View
More |
| 7919786
|
Protein structure--based drug design. |
Annu Rev Biophys Biomol Struct |
1994 |
Whittle PJ;Blundell TL |
View
More |
| 8698636
|
Novel triterpene sulfates from Fusarium compactum using a rhinovirus 3C protease inhibitor screen. |
J Antibiot (Tokyo) |
1996 |
Brill GM;Kati WM;Montgomery D;Karwowski JP;Humphrey PE;Jackson M;Clement JJ;Kadam S;Chen RH;McAlpine JB |
View
More |
| 9989947
|
Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides. |
Arch Biochem Biophys |
1999 |
Kati WM;Sham HL;McCall JO;Montgomery DA;Wang GT;Rosenbrook W;Miesbauer L;Buko A;Norbeck DW |
View
More |
